Gene activity may help show which IDH brain tumors grow faster
Original title: One-Carbon Metabolic Reprogramming Stratifies Prognosis and Defines Distinct Biological States in IDH1-Mutant Gliomas
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This used stored tumor data and cells in a dish, not a treatment tested in people.
The short version
Scientists looked for a sign of which IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary brain tumors may be more harmful.
What was studied. Researchers looked at gene records from 709 brain tumors called gliomas, with and without an IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary change. They checked 64 genes that help cells use certain nutrients to grow, and they tested tumor cells in a dish.
What they found. Most tumors with an IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary change had low activity in these genes. But one group had high activity, and those patients had a higher risk of dying. In the lab, the more aggressive cells were less flexible and depended on certain nutrients.
What this means, and what it doesn't
What it could mean: Someday, this gene pattern might help doctors spot which IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary tumors are higher risk. It might also point to new treatment ideas for tumors that may not respond to IDH-blocking drugs.
What it doesn't mean: This is early lab and data work. It is not a new test or treatment. Nothing was tested as a treatment in people. It is far from everyday care, and it is not a cure.
Source: bioRxiv (preprint), September 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.